The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BioCentury RFK Jr.'s peptide deregulation threatens the foundations of drug safety Is BPC 157 Banned? Oral vs. Injectable Forms Explained Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences RFK Jr. and the Perils of Peptides Washington Monthly Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives